Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 7426 to 7440 of 8899 results

  1. Palliative photodynamic therapy for advanced oesophageal cancer (IPG206)

    We have moved interventional procedures guidance 206 to become HealthTech guidance 132. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  2. Deep brain stimulation for tremor and dystonia (excluding Parkinson's disease) (IPG188)

    We have moved interventional procedures guidance 188 to become HealthTech guidance 122. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  3. Carotid artery stent placement for carotid stenosis (IPG191)

    This guidance has been updated and replaced by NICE HealthTech guidance 258.

    Withdrawn guidance

  4. Intrauterine laser ablation of placental vessels for the treatment of twin-to-twin transfusion syndrome (IPG198)

    We have moved interventional procedures guidance 198 to become HealthTech guidance 126. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  5. Thoracoscopically assisted oesophagectomy (IPG189)

    This guidance has been updated and replaced by NICE HealthTech guidance 272.

    Withdrawn guidance

  6. Selective dorsal rhizotomy for spasticity in cerebral palsy (IPG195)

    This guidance has been updated and replaced by NICE HealthTech guidance 245.

    Withdrawn guidance

  7. Therapeutic amnioinfusion for oligohydramnios during pregnancy (excluding labour) (IPG192)

    We have moved interventional procedures guidance 192 to become HealthTech guidance 124. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  8. Septostomy with or without amnioreduction for the treatment of twin-to-twin transfusion syndrome (IPG199)

    We have moved interventional procedures guidance 199 to become HealthTech guidance 127. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  9. Balloon kyphoplasty for vertebral compression fractures (IPG20)

    This guidance has been updated and replaced by NICE interventional procedure guidance 166.

    Withdrawn guidance

  10. Patient safety and reduction of risk of transmission of Creutzfeldt–Jakob disease (CJD) via interventional procedures (IPG196)

    This guidance has been updated and replaced by NICE HealthTech guidance 535.

    Withdrawn guidance

  11. Open femoro-acetabular surgery for hip impingement syndrome (IPG203)

    This guidance has been updated and replaced by NICE HealthTech guidance 270.

    Withdrawn guidance

  12. Radiofrequency ablation of hepatocellular carcinoma (IPG2)

    We have moved interventional procedures guidance 2 to become HealthTech guidance 1. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  13. Radiofrequency treatment for haemorrhoids (IPG589)

    We have moved interventional procedures guidance 589 to become HealthTech guidance 447. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  14. Ab interno supraciliary microstent insertion with phacoemulsification for primary open-angle glaucoma (IPG605)

    October 2018: The device used in this procedure (CyPass) has been withdrawn by the manufacturer Alcon, because of concerns about its long-term safety. Further details can be found in the Voluntary Field Safety Notice issued by Alcon. Surgeons are advised not to implant this device, to return any unused devices to Alcon and to consider reviewing any patients who have already been implanted with CyPass. Therefore NICE has decided to withdraw its guidance. NICE would consider whether to issue new guidance on ab interno supraciliary microstent insertion with phacoemulsification for primary open-angle glaucoma should evidence using an appropriately CE marked device become available.

    Withdrawn guidance

  15. Falloposcopy with coaxial catheter (IPG62)

    We have moved interventional procedures guidance 62 to become HealthTech guidance 35. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance